Xavier Martinez

Articles by Xavier Martinez

FDA Panel Votes In Favor of Replimune’s Melanoma Treatment - WSJ

Business August 1, 2026

A Food and Drug Administration advisory panel voted 10-3 Thursday for Replimune Groups experimental melanoma therapy, after a contentious meeting in which experts raised doubts about whether the compοΏ½...